CUBIST PHARMACEUTICALS INC's ticker is CBST and the CUSIP is 229678107. A total of 253 filers reported holding CUBIST PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $25,716,000 | +6187.5% | 255,500 | +4254.1% | 0.15% | +4933.3% |
Q2 2014 | $409,000 | -96.2% | 5,868 | -96.2% | 0.00% | -95.6% |
Q4 2013 | $10,699,000 | +34.5% | 155,355 | +24.2% | 0.07% | -12.8% |
Q3 2013 | $7,952,000 | +34.4% | 125,120 | +2.1% | 0.08% | +21.9% |
Q2 2013 | $5,916,000 | – | 122,495 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 1,336,136 | $92,020,000 | 8.58% |
Cormorant Asset Management, LP | 400,000 | $27,548,000 | 8.00% |
HealthCor Management, L.P. | 1,400,000 | $96,418,000 | 5.86% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,000,000 | $68,870,000 | 3.57% |
SECTOR GAMMA AS | 176,090 | $12,127,000 | 3.27% |
EAGLE BOSTON INVESTMENT MANAGEMENT INC | 698,376 | $48,097,000 | 2.33% |
Ghost Tree Capital, LLC | 50,000 | $3,444,000 | 2.12% |
Duquesne Family Office | 413,000 | $28,443,000 | 1.90% |
Rail-Splitter Capital Management, LLC | 78,900 | $5,434,000 | 1.88% |
MAZAMA CAPITAL MANAGEMENT INC | 50,891 | $3,505,000 | 1.74% |